Biofrontera(BFRI)
$0.94+0.01 (+0.97%)
BFRI
Biofrontera financials statements
$0.94
At close:+0.01 (+0.97%)
Want to see BFRI full AI Analyst Report?
Biofrontera (BFRI) Ratios
223 Followers
Biofrontera Ratios
BFRI's free cash flow for Q2 2026 was $-1.66M. For the 2026 fiscal year, BFRI's free cash flow was increased by $0.00 and operating cash flow was $-1.66M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.52 | 1.72 | 1.28 | 2.06 | 3.36 |
| Quick Ratio | 1.40 | 1.17 | 0.67 | 1.72 | 3.03 |
| Cash Ratio | 0.54 | 0.49 | 0.07 | 0.82 | 1.77 |
| Solvency Ratio | -0.53 | -0.94 | -0.82 | 0.02 | -0.89 |
| Operating Cash Flow Ratio | -1.12 | -0.85 | -1.38 | -0.78 | -1.93 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | -6.38 | 0.00 | 0.00 |
| Net Current Asset Value | $ -1.00K | $ 3.03M | $ -64.00K | $ 16.13M | $ 4.54M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.22 | 0.22 | 0.19 | 0.03 | 0.00 |
| Debt-to-Equity Ratio | 0.59 | 1.11 | 1.13 | 0.06 | 0.00 |
| Debt-to-Capital Ratio | 0.37 | 0.53 | 0.53 | 0.05 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.36 | 0.48 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.73 | 4.99 | 5.83 | 2.13 | 4.69 |
| Debt Service Coverage Ratio | -20.39 | -6.87 | -4.10 | 2.44 | -102.26 |
| Interest Coverage Ratio | -20.24 | -8.17 | -37.80 | -50.22 | -70.00 |
| Debt to Market Cap | 1.01 | 0.68 | 0.91 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.65 | 1.27 | 3.88 | 1.62 | 0.42 |
| Net Debt to EBITDA | 0.03 | 0.07 | -0.22 | -16.98 | 0.67 |
| Profitability Margins | |||||
| Gross Profit Margin | 78.65% | 50.12% | 48.80% | 47.04% | 47.13% |
| EBIT Margin | -24.12% | -41.90% | -57.28% | -0.83% | -154.76% |
| EBITDA Margin | -22.04% | -38.71% | -54.16% | 3.26% | -152.52% |
| Operating Profit Margin | -21.94% | -46.14% | -66.56% | -64.80% | -104.57% |
| Pretax Profit Margin | -25.20% | -47.55% | -59.04% | -2.12% | -156.25% |
| Net Profit Margin | -25.26% | -47.61% | -59.09% | -2.23% | -156.49% |
| Continuous Operations Profit Margin | -25.26% | -47.61% | -59.09% | -2.23% | -156.49% |
| Net Income Per EBT | 100.24% | 100.12% | 100.07% | 105.26% | 100.15% |
| EBT Per EBIT | 114.90% | 103.06% | 88.71% | 3.27% | 149.43% |
| Return on Assets (ROA) | -36.89% | -80.35% | -72.07% | -1.26% | -70.86% |
| Return on Equity (ROE) | -100.53% | -400.61% | -420.01% | -2.68% | -332.62% |
| Return on Capital Employed (ROCE) | -54.88% | -170.73% | -230.36% | -61.96% | -63.99% |
| Return on Invested Capital (ROIC) | -53.81% | -161.93% | -157.05% | -60.95% | -63.99% |
| Return on Tangible Assets | -40.66% | -80.48% | -79.56% | -1.34% | -75.78% |
| Earnings Yield | -181.72% | -295.35% | -469.99% | -3.30% | -29.32% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.72 | 7.02 | 6.60 | 3.87 | 6.37 |
| Payables Turnover | 4.80 | 10.03 | 1.96 | 11.88 | 19.36 |
| Inventory Turnover | 6.24 | 2.80 | 1.60 | 2.12 | 2.86 |
| Fixed Asset Turnover | 11.15 | 37.95 | 19.51 | 18.16 | 90.26 |
| Asset Turnover | 1.46 | 1.69 | 1.22 | 0.56 | 0.45 |
| Working Capital Turnover Ratio | 5.61 | 5.46 | 2.50 | 1.05 | 1.01 |
| Cash Conversion Cycle | 46.22 | 145.97 | 97.19 | 235.85 | 166.16 |
| Days of Sales Outstanding | 63.81 | 52.01 | 55.30 | 94.27 | 57.31 |
| Days of Inventory Outstanding | 58.47 | 130.37 | 228.24 | 172.30 | 127.70 |
| Days of Payables Outstanding | 76.06 | 36.41 | 186.35 | 30.72 | 18.85 |
| Operating Cycle | 122.28 | 182.38 | 283.54 | 266.57 | 185.01 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.31 | -1.86 | -16.10 | -15.33 | -31.24 |
| Free Cash Flow Per Share | -1.31 | -1.87 | -16.10 | -15.36 | -31.25 |
| Dividend Paid and CapEx Coverage Ratio | -6680.50 | -171.17 | -4979.00 | -426.29 | -2428.64 |
| Capital Expenditure Coverage Ratio | -6680.50 | -171.17 | -4979.00 | -426.29 | -2428.64 |
| Operating Cash Flow Coverage Ratio | -2.17 | -2.09 | -4.61 | -12.03 | 0.00 |
| Operating Cash Flow to Sales Ratio | -0.32 | -0.28 | -0.73 | -0.56 | -1.11 |
| Free Cash Flow Yield | -230.48% | -171.80% | -581.34% | -83.76% | -20.78% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.55 | -0.34 | -0.21 | -30.29 | -3.41 |
| Price-to-Sales (P/S) Ratio | 0.14 | 0.16 | 0.13 | 0.68 | 5.34 |
| Price-to-Book (P/B) Ratio | 0.55 | 1.36 | 0.89 | 0.81 | 11.34 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.43 | -0.58 | -0.17 | -1.19 | -4.81 |
| Price-to-Operating Cash Flow Ratio | -0.43 | -0.59 | -0.17 | -1.20 | -4.81 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.00 | -0.00 | 0.31 | -0.03 |
| Enterprise Value Multiple | -0.61 | -0.35 | -0.45 | 3.77 | -2.83 |
| Enterprise Value | 5.57M | 5.03M | 8.34M | 3.52M | 104.08M |
| EV to EBITDA | -0.61 | -0.35 | -0.45 | 3.77 | -2.83 |
| EV to Sales | 0.13 | 0.13 | 0.24 | 0.12 | 4.32 |
| EV to Free Cash Flow | -0.42 | -0.49 | -0.33 | -0.22 | -3.89 |
| EV to Operating Cash Flow | -0.42 | -0.49 | -0.33 | -0.22 | -3.90 |
| Tangible Book Value Per Share | 0.77 | 0.80 | 1.40 | 19.72 | 9.22 |
| Shareholders’ Equity Per Share | 1.03 | 0.80 | 3.10 | 22.59 | 13.26 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | -0.05 | -0.00 |
| Revenue Per Share | 4.10 | 6.76 | 22.03 | 27.13 | 28.18 |
| Net Income Per Share | -1.04 | -3.22 | -13.02 | -0.61 | -44.10 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.05 | 1.00 |
| Interest Burden | 1.04 | 1.13 | 1.03 | 2.55 | 1.01 |
| Research & Development to Revenue | 0.09 | 0.06 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.91 | 0.91 | 1.11 | 1.25 | 1.54 |
| Stock-Based Compensation to Revenue | 0.02 | 0.03 | 0.03 | 0.06 | 0.01 |
| Income Quality | 1.27 | 0.58 | 1.24 | 25.31 | 0.71 |
Currency in USD
